141 related articles for article (PubMed ID: 33607825)
1. A nomogram predicting subclinical extension of cutaneous squamous cell carcinoma in Chinese individuals: A retrospective study.
Lin P; Zhu S; Zhang G; Huang Y; Tu P; Yang S; Li H
Medicine (Baltimore); 2021 Feb; 100(7):e24767. PubMed ID: 33607825
[TBL] [Abstract][Full Text] [Related]
2. Outcomes in intermediate-risk squamous cell carcinomas treated with Mohs micrographic surgery compared with wide local excision.
Xiong DD; Beal BT; Varra V; Rodriguez M; Cundall H; Woody NM; Vidimos AT; Koyfman SA; Knackstedt TJ
J Am Acad Dermatol; 2020 May; 82(5):1195-1204. PubMed ID: 31887322
[TBL] [Abstract][Full Text] [Related]
3. Deep initial Mohs stage for scalp cutaneous squamous cell carcinoma to avoid occult tumor.
Lederhandler M; Stokar E; Meehan SA; Geronemus RG
J Am Acad Dermatol; 2020 Apr; 82(4):e129-e130. PubMed ID: 31836558
[No Abstract] [Full Text] [Related]
4. Surgical margins for excision of primary cutaneous squamous cell carcinoma.
Brodland DG; Zitelli JA
J Am Acad Dermatol; 1992 Aug; 27(2 Pt 1):241-8. PubMed ID: 1430364
[TBL] [Abstract][Full Text] [Related]
5. Melanomas of the head and neck have high-local recurrence risk features and require tissue-rearranging reconstruction more commonly than basal cell carcinoma and squamous cell carcinoma: A comparison of indications for microscopic margin control prior to reconstruction in 13,664 tumors.
Fix W; Etzkorn JR; Shin TM; Howe N; Bhatt M; Sobanko JF; Miller CJ
J Am Acad Dermatol; 2021 Aug; 85(2):409-418. PubMed ID: 30458206
[TBL] [Abstract][Full Text] [Related]
6. Validation of the 2022 National Comprehensive Cancer Network Risk Stratification for Cutaneous Squamous Cell Carcinoma.
Stevens JS; Murad F; Smile TD; O'Connor DM; Ilori E; Koyfman S; Vidimos A; Waldman AB; Ruiz ES
JAMA Dermatol; 2023 Jul; 159(7):728-735. PubMed ID: 37285135
[TBL] [Abstract][Full Text] [Related]
7. Suggested excisional margins for cutaneous malignant lesions based on Mohs micrographic surgery.
Schell AE; Russell MA; Park SS
JAMA Facial Plast Surg; 2013; 15(5):337-43. PubMed ID: 23744451
[TBL] [Abstract][Full Text] [Related]
8. A nomogram combining clinical factors and biomarkers for predicting the recurrence of high-risk cutaneous squamous cell carcinoma.
Oh Y; Zheng Z; Kim KY; Xu X; Pei M; Oh B; Kim SK; Chung KY; Roh MR
BMC Cancer; 2022 Nov; 22(1):1126. PubMed ID: 36324094
[TBL] [Abstract][Full Text] [Related]
9. Low recurrence rates for challenging squamous cell carcinomas using Mohs micrographic surgery with AE1/AE3 cytokeratin immunostaining.
Aizman L; Miller CJ; Perz AM; Lukowiak TM; Cohen OG; Bean E; Hitchner MK; Etzkorn JR; Shin TM; Higgins HW; Giordano CN; Cohen JV; Miura JT; Sobanko JF
J Am Acad Dermatol; 2021 May; 84(5):1453-1455. PubMed ID: 32622892
[No Abstract] [Full Text] [Related]
10. Characteristics of non-melanoma skin cancers of the cutaneous perioral and vermilion lip treated by Mohs micrographic surgery.
Queen D; Knackstedt T; Polacco MA; Collins LK; Lee K; Samie FH
J Eur Acad Dermatol Venereol; 2019 Feb; 33(2):305-311. PubMed ID: 30284728
[TBL] [Abstract][Full Text] [Related]
11. Cutaneous squamous cell carcinoma treated with Mohs micrographic surgery in Australia II. Perineural invasion.
Leibovitch I; Huilgol SC; Selva D; Hill D; Richards S; Paver R
J Am Acad Dermatol; 2005 Aug; 53(2):261-6. PubMed ID: 16021121
[TBL] [Abstract][Full Text] [Related]
12. Combined sentinel lymphadenectomy and mohs micrographic surgery for high-risk cutaneous squamous cell carcinoma.
Weisberg NK; Bertagnolli MM; Becker DS
J Am Acad Dermatol; 2000 Sep; 43(3):483-8. PubMed ID: 10954660
[TBL] [Abstract][Full Text] [Related]
13. Long-term clinical outcomes of patients with invasive cutaneous squamous cell carcinoma treated with Mohs micrographic surgery: A 5-year, multicenter, prospective cohort study.
Tschetter AJ; Campoli MR; Zitelli JA; Brodland DG
J Am Acad Dermatol; 2020 Jan; 82(1):139-148. PubMed ID: 31279037
[TBL] [Abstract][Full Text] [Related]
14. A prospective evaluation of the clinical, histologic, and therapeutic variables associated with incidental perineural invasion in cutaneous squamous cell carcinoma.
Campoli M; Brodland DG; Zitelli J
J Am Acad Dermatol; 2014 Apr; 70(4):630-636. PubMed ID: 24433872
[TBL] [Abstract][Full Text] [Related]
15. Clinical outcomes in high-risk squamous cell carcinoma patients treated with Mohs micrographic surgery alone.
Marrazzo G; Zitelli JA; Brodland D
J Am Acad Dermatol; 2019 Mar; 80(3):633-638. PubMed ID: 30244064
[TBL] [Abstract][Full Text] [Related]
16. High recurrence rates of squamous cell carcinoma after Mohs' surgery in patients with chronic lymphocytic leukemia.
Mehrany K; Weenig RH; Pittelkow MR; Roenigk RK; Otley CC
Dermatol Surg; 2005 Jan; 31(1):38-42; discussion 42. PubMed ID: 15720094
[TBL] [Abstract][Full Text] [Related]
17. Predictors of extensive subclinical spread in nonmelanoma skin cancer treated with Mohs micrographic surgery.
Batra RS; Kelley LC
Arch Dermatol; 2002 Aug; 138(8):1043-51. PubMed ID: 12164742
[TBL] [Abstract][Full Text] [Related]
18. Squamous cell carcinoma with aggressive subclinical extension: 5-year retrospective review of diagnostic predictors.
Goldenberg A; Ortiz A; Kim SS; Jiang SB
J Am Acad Dermatol; 2015 Jul; 73(1):120-6. PubMed ID: 25840729
[TBL] [Abstract][Full Text] [Related]
19. Squamous Cell Carcinoma in Situ Achieves Tumor Clearance in More Mohs Stages Than Invasive Squamous Cell Carcinoma.
Kim Y; Khan AH; Papachristou C; Decker A; Lawrence N
Dermatol Surg; 2023 Dec; 49(12):1104-1107. PubMed ID: 38019009
[TBL] [Abstract][Full Text] [Related]
20. Using frozen section margin control technique to manage non-melanomatous skin lesions in high-risk sites.
Nizamoglu M; Douglas H; McArdle C; Mathew B; Vize C; Matteucci P
J Plast Reconstr Aesthet Surg; 2016 May; 69(5):657-62. PubMed ID: 26850755
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
